Ebola vaccine trial launches in DRC amid largest Bundibugyo outbreak
Published 2 d ago4 sourcesEvidence: Reported
A trial of Merck's Ervebo and an experimental Moderna vaccine against the Bundibugyo Ebola species has begun in Bunia, DRC, where the outbreak is concentrated. The trial tests cross-protection and a new mRNA candidate, but efficacy data will take months. This is the first targeted response to a strain that has historically lacked a licensed vaccine.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago4 sourcesEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 5 h ago3 sourcesEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 3 d ago5 sourcesEvidence: Reported